Estimated costs comparable to 1.8 percent of GDP across eight countries in 2019; economic impact projected to increase to 3.6 percent by 2060
FRIDAY, Nov. 5, 2021 (HealthDay News) — The estimated economic impact of obesity is considerable across countries, with costs comparable to 1.8 percent of gross domestic product (GDP) on average in 2019 across eight countries representing different geographic regions and income levels, according to a study published online Nov. 4 in BMJ Global Health.
Adeyemi Okunogbe, M.D., from RTI International in Washington, D.C., and colleagues used a cost-of-illness approach to estimate the economic impacts of overweight and obesity for eight countries. From 2019 to 2060, the direct and indirect costs of obesity were estimated from a societal perspective.
The researchers found that the costs of obesity in per-capita terms ranged from $17 in India to $940 in Australia in 2019. On average, these economic costs are comparable to 1.8 percent of GDP across the eight countries, ranging from 0.8 to 2.4 percent of GDP in India and Saudi Arabia, respectively. With no significant changes to the status quo, the economic impacts from obesity are projected to increase to 3.6 percent of GDP on average by 2060, ranging from 2.4 to 4.9 percent of GDP in Spain and Thailand, respectively. Between 2020 and 2060, across the eight countries, an average annual reduction of 5.2 and 13.2 percent in economic costs would be seen by reducing obesity prevalence by 5 percent or keeping it at 2019 levels, respectively.
“The findings of this study will be helpful to further strengthen political commitment for national obesity control efforts in these countries,” the authors write. “This is greatly needed to achieve levels of investment commensurate to the economic impact.”
Several authors disclosed financial ties to pharmaceutical companies, including Novo Nordisk, which partially funded the study.
Calorie Restriction and Mediterranean-Style Diet Yield Similar Weight Loss
Strength Training May Cut GDM Risk in Pregnant Women With Overweight, Obesity
Most Metabolic and Bariatric Surgery Candidates Meet Criteria for Clinical Obesity
Central Adiposity Reclassifies Cardiovascular Risk Across BMI Spectrum
2011 to 2021 Saw Heart Failure-Related Hospitalization Rise in CKD
Machine Learning Model IDs Heart Failure With Reduced Ejection Fraction Using Routine Lab Indicators
Reinitiating Obesity Meds After Bariatric Surgery Tied to Greater One-Year Weight Loss in Youths
High-Dose Omega-3 Linked to A-Fib Risk in Patients With High CVD Risk